Review



d f 3d reconstruction immunofluorescence image  (Oxford Instruments)


Bioz Verified Symbol Oxford Instruments is a verified supplier
Bioz Manufacturer Symbol Oxford Instruments manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    Oxford Instruments d f 3d reconstruction immunofluorescence image
    D F 3d Reconstruction Immunofluorescence Image, supplied by Oxford Instruments, used in various techniques. Bioz Stars score: 99/100, based on 43744 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d+immunofluorescence+images/pm38225752-190-0-6?v=Oxford+Instruments
    Average 99 stars, based on 43744 article reviews
    d f 3d reconstruction immunofluorescence image - by Bioz Stars, 2026-08
    99/100 stars

    Images



    Similar Products

    d immunofluorescence images  (Human Protein Atlas)
    86
    Human Protein Atlas d immunofluorescence images
    Expression pattern and diagnostic value of IFI30 in stomach adenocarcinoma (STAD). A Pan-cancer integrated analysis of TCGA and GTEx datasets showing significantly elevated IFI30 mRNA levels in STAD tissues compared with normal gastric tissues. B Paired-sample analysis from the TCGA cohort confirming consistently higher IFI30 expression in gastric cancer tissues relative to matched adjacent normal tissues. C Multi-tissue heat-map visualization based on the pan-cancer TCGA-GTEx database demonstrates up-regulation of IFI30 across gastrointestinal and immune-related malignancies, with the most pronounced elevation in STAD. D <t>Immunofluorescence</t> images from the Human Protein Atlas (HPA) showing robust colocalization of IFI30 with the endoplasmic reticulum (ER), indicating its predominant ER–lysosomal subcellular localization. E Analysis of the TCGA dataset showing significantly higher IFI30 expression in gastric cancer tissues versus normal gastric tissues, validated by paired-sample analysis; receiver operating characteristic (ROC) curve analysis demonstrating strong diagnostic performance of IFI30 expression for distinguishing STAD from normal gastric tissues (AUC = 0.92; 95% CI: 0.89–0.95). Statistical significance: *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
    D Immunofluorescence Images, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d+immunofluorescence+images/pmc12917288-28-0-5?v=Human+Protein+Atlas
    Average 86 stars, based on 1 article reviews
    d immunofluorescence images - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    real time pcr b cloning b fluorescence activated cell sorting facs b immunofluorescence b live imaging d quantification  (10X Genomics)
    86
    10X Genomics real time pcr b cloning b fluorescence activated cell sorting facs b immunofluorescence b live imaging d quantification
    Expression pattern and diagnostic value of IFI30 in stomach adenocarcinoma (STAD). A Pan-cancer integrated analysis of TCGA and GTEx datasets showing significantly elevated IFI30 mRNA levels in STAD tissues compared with normal gastric tissues. B Paired-sample analysis from the TCGA cohort confirming consistently higher IFI30 expression in gastric cancer tissues relative to matched adjacent normal tissues. C Multi-tissue heat-map visualization based on the pan-cancer TCGA-GTEx database demonstrates up-regulation of IFI30 across gastrointestinal and immune-related malignancies, with the most pronounced elevation in STAD. D <t>Immunofluorescence</t> images from the Human Protein Atlas (HPA) showing robust colocalization of IFI30 with the endoplasmic reticulum (ER), indicating its predominant ER–lysosomal subcellular localization. E Analysis of the TCGA dataset showing significantly higher IFI30 expression in gastric cancer tissues versus normal gastric tissues, validated by paired-sample analysis; receiver operating characteristic (ROC) curve analysis demonstrating strong diagnostic performance of IFI30 expression for distinguishing STAD from normal gastric tissues (AUC = 0.92; 95% CI: 0.89–0.95). Statistical significance: *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
    Real Time Pcr B Cloning B Fluorescence Activated Cell Sorting Facs B Immunofluorescence B Live Imaging D Quantification, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d+immunofluorescence+images/pm38579720-343-134-117?v=10X+Genomics
    Average 86 stars, based on 1 article reviews
    real time pcr b cloning b fluorescence activated cell sorting facs b immunofluorescence b live imaging d quantification - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    d f 3d reconstruction immunofluorescence image  (Oxford Instruments)
    99
    Oxford Instruments d f 3d reconstruction immunofluorescence image
    Expression pattern and diagnostic value of IFI30 in stomach adenocarcinoma (STAD). A Pan-cancer integrated analysis of TCGA and GTEx datasets showing significantly elevated IFI30 mRNA levels in STAD tissues compared with normal gastric tissues. B Paired-sample analysis from the TCGA cohort confirming consistently higher IFI30 expression in gastric cancer tissues relative to matched adjacent normal tissues. C Multi-tissue heat-map visualization based on the pan-cancer TCGA-GTEx database demonstrates up-regulation of IFI30 across gastrointestinal and immune-related malignancies, with the most pronounced elevation in STAD. D <t>Immunofluorescence</t> images from the Human Protein Atlas (HPA) showing robust colocalization of IFI30 with the endoplasmic reticulum (ER), indicating its predominant ER–lysosomal subcellular localization. E Analysis of the TCGA dataset showing significantly higher IFI30 expression in gastric cancer tissues versus normal gastric tissues, validated by paired-sample analysis; receiver operating characteristic (ROC) curve analysis demonstrating strong diagnostic performance of IFI30 expression for distinguishing STAD from normal gastric tissues (AUC = 0.92; 95% CI: 0.89–0.95). Statistical significance: *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
    D F 3d Reconstruction Immunofluorescence Image, supplied by Oxford Instruments, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d+immunofluorescence+images/pm38225752-190-0-6?v=Oxford+Instruments
    Average 99 stars, based on 1 article reviews
    d f 3d reconstruction immunofluorescence image - by Bioz Stars, 2026-08
    99/100 stars
    		  Buy from Supplier
    immunofluorescence images  (Carl Zeiss)
    96
    Carl Zeiss immunofluorescence images
    Expression pattern and diagnostic value of IFI30 in stomach adenocarcinoma (STAD). A Pan-cancer integrated analysis of TCGA and GTEx datasets showing significantly elevated IFI30 mRNA levels in STAD tissues compared with normal gastric tissues. B Paired-sample analysis from the TCGA cohort confirming consistently higher IFI30 expression in gastric cancer tissues relative to matched adjacent normal tissues. C Multi-tissue heat-map visualization based on the pan-cancer TCGA-GTEx database demonstrates up-regulation of IFI30 across gastrointestinal and immune-related malignancies, with the most pronounced elevation in STAD. D <t>Immunofluorescence</t> images from the Human Protein Atlas (HPA) showing robust colocalization of IFI30 with the endoplasmic reticulum (ER), indicating its predominant ER–lysosomal subcellular localization. E Analysis of the TCGA dataset showing significantly higher IFI30 expression in gastric cancer tissues versus normal gastric tissues, validated by paired-sample analysis; receiver operating characteristic (ROC) curve analysis demonstrating strong diagnostic performance of IFI30 expression for distinguishing STAD from normal gastric tissues (AUC = 0.92; 95% CI: 0.89–0.95). Statistical significance: *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
    Immunofluorescence Images, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d+immunofluorescence+images/pm30206235-350-39-44?v=Carl+Zeiss
    Average 96 stars, based on 1 article reviews
    immunofluorescence images - by Bioz Stars, 2026-08
    96/100 stars
    		  Buy from Supplier
    d immunofluorescence images  (Oxford Instruments)
    99
    Oxford Instruments d immunofluorescence images
    Expression pattern and diagnostic value of IFI30 in stomach adenocarcinoma (STAD). A Pan-cancer integrated analysis of TCGA and GTEx datasets showing significantly elevated IFI30 mRNA levels in STAD tissues compared with normal gastric tissues. B Paired-sample analysis from the TCGA cohort confirming consistently higher IFI30 expression in gastric cancer tissues relative to matched adjacent normal tissues. C Multi-tissue heat-map visualization based on the pan-cancer TCGA-GTEx database demonstrates up-regulation of IFI30 across gastrointestinal and immune-related malignancies, with the most pronounced elevation in STAD. D <t>Immunofluorescence</t> images from the Human Protein Atlas (HPA) showing robust colocalization of IFI30 with the endoplasmic reticulum (ER), indicating its predominant ER–lysosomal subcellular localization. E Analysis of the TCGA dataset showing significantly higher IFI30 expression in gastric cancer tissues versus normal gastric tissues, validated by paired-sample analysis; receiver operating characteristic (ROC) curve analysis demonstrating strong diagnostic performance of IFI30 expression for distinguishing STAD from normal gastric tissues (AUC = 0.92; 95% CI: 0.89–0.95). Statistical significance: *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
    D Immunofluorescence Images, supplied by Oxford Instruments, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d+immunofluorescence+images/pmc06208885-205-0-7?v=Oxford+Instruments
    Average 99 stars, based on 1 article reviews
    d immunofluorescence images - by Bioz Stars, 2026-08
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    Expression pattern and diagnostic value of IFI30 in stomach adenocarcinoma (STAD). A Pan-cancer integrated analysis of TCGA and GTEx datasets showing significantly elevated IFI30 mRNA levels in STAD tissues compared with normal gastric tissues. B Paired-sample analysis from the TCGA cohort confirming consistently higher IFI30 expression in gastric cancer tissues relative to matched adjacent normal tissues. C Multi-tissue heat-map visualization based on the pan-cancer TCGA-GTEx database demonstrates up-regulation of IFI30 across gastrointestinal and immune-related malignancies, with the most pronounced elevation in STAD. D Immunofluorescence images from the Human Protein Atlas (HPA) showing robust colocalization of IFI30 with the endoplasmic reticulum (ER), indicating its predominant ER–lysosomal subcellular localization. E Analysis of the TCGA dataset showing significantly higher IFI30 expression in gastric cancer tissues versus normal gastric tissues, validated by paired-sample analysis; receiver operating characteristic (ROC) curve analysis demonstrating strong diagnostic performance of IFI30 expression for distinguishing STAD from normal gastric tissues (AUC = 0.92; 95% CI: 0.89–0.95). Statistical significance: *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

    Journal: Scientific Reports

    Article Title: Copy-number amplification drives IFI30 overexpression and coordinated immune activation, identifying a novel diagnostic and therapeutic target in gastric adenocarcinoma

    doi: 10.1038/s41598-026-37574-z

    Figure Lengend Snippet: Expression pattern and diagnostic value of IFI30 in stomach adenocarcinoma (STAD). A Pan-cancer integrated analysis of TCGA and GTEx datasets showing significantly elevated IFI30 mRNA levels in STAD tissues compared with normal gastric tissues. B Paired-sample analysis from the TCGA cohort confirming consistently higher IFI30 expression in gastric cancer tissues relative to matched adjacent normal tissues. C Multi-tissue heat-map visualization based on the pan-cancer TCGA-GTEx database demonstrates up-regulation of IFI30 across gastrointestinal and immune-related malignancies, with the most pronounced elevation in STAD. D Immunofluorescence images from the Human Protein Atlas (HPA) showing robust colocalization of IFI30 with the endoplasmic reticulum (ER), indicating its predominant ER–lysosomal subcellular localization. E Analysis of the TCGA dataset showing significantly higher IFI30 expression in gastric cancer tissues versus normal gastric tissues, validated by paired-sample analysis; receiver operating characteristic (ROC) curve analysis demonstrating strong diagnostic performance of IFI30 expression for distinguishing STAD from normal gastric tissues (AUC = 0.92; 95% CI: 0.89–0.95). Statistical significance: *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

    Article Snippet: D Immunofluorescence images from the Human Protein Atlas (HPA) showing robust colocalization of IFI30 with the endoplasmic reticulum (ER), indicating its predominant ER–lysosomal subcellular localization.

    Techniques: Expressing, Diagnostic Assay, Immunofluorescence